News: CBE

Daniel group

A Boost for New COVID-19 Research

Cornell researchers are already making strides against COVID-19. The Cornell faculty boasts world-class virologists, such as Diego Diel, Population Medicine and Diagnostic Sciences, and Hector Aguilar-Carreno, Microbiology and Immunology. Cornell is also home to renowned coronavirus experts Susan Daniel, Chemical and Biomolecular Engineering, and Gary Whittaker, Microbiology and Immunology. Read more

Fengqi You

Website charts COVID-19 spread across NY state

“When we had to shut down our lab, we wanted to see what we could do with our expertise in systems engineering to help the public and provide timely information,” said Fengqi You , the Roxanne E. and Michael J. Zak Professor in Energy Systems Engineering, who is leading the effort. “We’re viewing this as a citizen science project, but one where accuracy and primary data are paramount.” Read more

Prof. You

The American Automatic Control Council (AACC) has awarded Dr. Fengqi You, and Chao Ning, the 2020 O. Hugo Schuck Award

The American Automatic Control Council (AACC) has awarded Dr. Fengqi You, Roxanne E. and Michael J. Zak Professor, and CBE PhD student, Chao Ning, the prestigious 2020 O. Hugo Schuck Award. The American Automatic Control Council (AACC) was formed in 1957 and represents the United States to the world automatic control community. Nine professional societies are current members of the AACC – the American Institute of Aeronautics and Astronautics (AIAA), American Institute of Chemical Engineers (AIChE), American Society of Civil Engineers (ASCE), American Society of Mechanical Engineers (ASME)... Read more

DeLisa

Cell-free biotech could drive COVID-19 therapeutics

A biomanufacturing company spun out of Cornell research is seeking to rapidly translate an antibody therapy against COVID-19 by using cell-free biotechnology based on glycoengineered bacteria. And it could scale up the production 10 times faster than conventional methods. The company, SwiftScale Biologics, was co-founded by Matt DeLisa , the William L. Lewis Professor of Engineering in the Robert F. Smith School of Chemical and Biomolecular Engineering, and his longtime collaborator, Michael Jewett, a professor of chemical and biological engineering at Northwestern University. Read more

Susan Daniel

Seeking COVID cures: Scientists find promising first step in antiviral treatment

Researchers from Cornell University have identified a possible target for antiviral treatment for COVID-19. The researchers initially set out to analyze the structure and characteristics of SARS-CoV (severe acute respiratory syndrome coronavirus) and MERS-CoV (Middle East respiratory syndrome coronavirus), with a focus on the spike protein – specifically the fusion peptide – that allows these viruses to infect cells by transferring their genome. As the current pandemic escalated, the researchers compared the biological sequences of the fusion peptides of SARS-CoV to SARS-CoV-2, the virus that... Read more

covid19

Bob Langer, ChemE '70, co-founder of Moderna Therapeutics, a company that develops treatments that leverage specialized transporter molecules in cells known as messenger RNAs

Bob Langer, ChemE '70, co-founder of Moderna Therapeutics, a company that develops treatments that leverage specialized transporter molecules in cells known as messenger RNAs. Messenger RNAs bring instructions from genes to the cellular machinery that makes proteins. By creating specially modified mRNA, Moderna believes it can develop therapies to treat and prevent a number of diseases in humans. http://news.mit.edu/2020/mit-companies-covid-19-0326 Read more

Bob Langer, ChemE '70, co-founder of Moderna Therapeutics, working to fight the COVID-19 pandemic

Bob Langer, ChemE '70, co-founder of Moderna Therapeutics, a company that develops treatments that leverage specialized transporter molecules in cells known as messenger RNAs. Messenger RNAs bring instructions from genes to the cellular machinery that makes proteins. By creating specially modified mRNA, Moderna believes it can develop therapies to treat and prevent a number of diseases in humans. http://news.mit.edu/2020/mit-companies-covid-19-0326 Read more